Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
Tetracore® Inc. Announces European Approval of the T-COR 8(TM) Portable Real-time PCR Thermocycler | ||
By: PR Newswire Association LLC. - 18 Sep 2017 | Back to overview list |
|
The next generation molecular diagnostics platform introduces novel connectivity solution designed to bring testing closer to the patient ROCKVILLE, Maryland, Sept. 18, 2017 /PRNewswire/ -- Tetracore today announced that the T-COR 8 portable real-time PCR thermocycler has achieved CE-IVD status under the European Directive on In Vitro Diagnostic Medical Devices. Logo - https://mma.prnewswire.com/media/371337/Tetracore_Logo.jpg The T-COR 8, and proprietary software delivers healthcare providers with a simple, flexible, and accessible molecular diagnostics platform. This unique, and easy to use point-of-care (POC) diagnostic system enables real-time molecular testing in hospitals, clinics, physician offices, and field applications. Healthcare providers rely on molecular testing to produce accurate identification of infectious agents to aid in selecting targeted therapies quickly. Advances in access to molecular testing support global clinical efforts to improve antibiotic stewardship. Most importantly, near patient diagnostics permits appropriate treatment to begin immediately. Designed for the point of care, the T-COR 8 brings molecular infectious disease testing closer to the patient. "We are focused on delivering testing to where it is most needed, regardless of the setting," explains Dr. Bill Nelson MD, CEO of Tetracore. "The T-COR 8 empowers more healthcare providers to perform critical tests where it is needed most." Tetracore is developing several diagnostic tests for the system targeting respiratory viruses, hospital acquired infections, and gastrointestinal infectious disease panels. Along with the proprietary content under development, the T-COR 8 is capable of performing molecular tests in an "open" mode, allowing researchers and developers to create new tests on the next generation instrument using the built-in custom protocol creator. The T-COR 8 Features Include:
About Tetracore, Inc. SOURCE Tetracore, Inc. |
||
|
||
Copyright 2017 PR Newswire Association LLC. | Back to overview list |